Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-12-22
1995-12-12
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514912, 514913, 514914, 514964, 424468, 424497, 424 7804, 424 7805, A61K 3119, A61K 31405, A61K 31195
Patent
active
054749859
ABSTRACT:
Methods and compositions for preventing or treating non-inflammatory elevated intraocular pressure associated with administered or endogenous steroids including administering to a mammalian organism a composition including (a) an ophthalmologically effective amount of a non-steroidal cyclooxygenase inhibitor, and (b) a pharmaceutically acceptable carrier, to reduce or prevent an elevation of intraocular pressure and/or protein marker induction induced by chronic exposure to glucocorticoids.
REFERENCES:
patent: 3732865 (1973-05-01), Higuchi et al.
patent: 4192827 (1980-03-01), Mueller
patent: 4327725 (1982-05-01), Cortese et al.
patent: 4454151 (1984-06-01), Waterbury
patent: 4522826 (1985-06-01), Sunshine et al.
patent: 4543251 (1985-09-01), Kamishita
patent: 4548990 (1985-10-01), Mueller et al.
patent: 4670254 (1987-06-01), Kamishita
patent: 4690927 (1987-09-01), Voss et al.
patent: 4711782 (1987-12-01), Okada et al.
patent: 4711906 (1987-12-01), von Stetten et al.
patent: 4757060 (1988-07-01), Lukacsko et al.
patent: 4777174 (1988-10-01), Sunshine et al.
patent: 4829088 (1989-05-01), Doulakas
patent: 4855293 (1989-08-01), Collington et al.
patent: 4876250 (1989-10-01), Clark
patent: 4880742 (1989-11-01), Hayaishi et al.
patent: 4904649 (1990-02-01), Schwartz
patent: 4917886 (1990-04-01), Asche et al.
patent: 4948805 (1990-08-01), Ziggiotti et al.
patent: 4960799 (1990-10-01), Nagy
patent: 4971802 (1990-11-01), Tarcsay et al.
patent: 4973469 (1990-11-01), Mulligan et al.
patent: 4980170 (1990-12-01), Schneider et al.
patent: 4999379 (1991-03-01), Fankhauser
patent: 5036097 (1991-07-01), Floyd et al.
patent: 5110493 (1992-05-01), Cherng-Chyi et al.
patent: 5124154 (1992-06-01), Babcock et al.
patent: 5314909 (1994-05-01), Dollerup
Huk, et al: Ophthalmologica, vol. 203, No. 1, 1991 (pp. 24-29)-"Anti-Inflammatory Treatment after Argon Laser Trabeculoplasty".
Icy Hot.RTM. distributed by Chattem Consumer Products.
Rite Aid Muscle Rub.RTM. distributed by Rite Aid.
Zambon Group (Bonadeo et al): Derwent Publications Ltd., London, GB (AN 93-220718)-Jul. 1993 Abstract.
Patent Abstracts of Japan, vol. 011, No. 349 (C-456) (Nov. 14, 1987) & JP A 62 123 119 (The Green Cross Corp.)-Jun. 4, 1987.
Weinreb et al: Investigative Ophthalmology & Visual Science, Dec. 1983 vol. 24/12-"Prostaglandin Production by Human Trabecular Cells": In Vitro Inhibition by Dexamethasone.
Klaus Trier, Elith Bjarne Olsen, "The Use of Estrogens in the Preparation of Formulations for Topical Treatment of High Pressure in the Eyes", 1992, Chemical Abstracts, vol. 117, p. 480.
J. R. Polansky, R. M. Kurtz, D. J. Fauss, R. Y. Kim and E. Bloom, "In Vitro Correlates of Glucocorticoid Effects of Intraocular Pressure", G. K. Krieglstein(Ed.), Glaucoma Update IV, 1991, pp. 20-29.
Allan J. Flach, M.D., Pharm. D., "Cyclo-oxygenase Inhibitors in Ophthalmology", Survey of Ophthalmology, vol. 36, No. 4, Jan.-Feb. 1992, pp. 259-284.
Jon R. Polansky, Ron M. Kurtz, Jorge A. Alvarado, Robert N. Weinreb, and Murray D. Mitchell, "Eicosanoid Production and Glucocorticoid Regulatory Mechanisms in Cultured Human Trabecular Meshwork Cells", Cellular Pharmacology Laboratory, University of California, The Oailor Effects of Prostaglandins and Other Eicosanoids, pp. 113-138 (1989) Alan R. Liss, Inc.
J. R. Polansky and R. N. Weinreb, "Anti-Inflammatory Agents: Steroids as Anti-Inflammatory Agents", Handbook of Experimental Pharmacology, vol. 69, pp. 491-503 (1984).
Jon Polansky, Paul Palmberg, Daniel Matulich, Nancy Lan, Shirley Hajek, Anthony Hajek, Bernard Becker and John Baxter, "Cellular Sensitivity to Glucocorticoids in Patients with POAG", Investigative Ophthalmology & Visual Science, vol. 26, No. 6, Jun. 1985, pp. 805-809.
John D. Mullins, Ph.D., Gerald Hecht, Ph.D. "Ophthalmic Preparations" Chapter 86, Remington's Pharmaceutical Sciences, 18th Ed., pp. 1581-1595 (1990).
Jack Hartstein, "Glaucoma", McGraw-Hill Encyclopedia of Science & Technology, 6th Ed., pp. 131-132 (1987).
Jack Hartstein, "Eye (vertebrate)", McGraw-Hill Encyclopedia of Science & Technology, 6th Ed., pp. 544-552 (1987).
Paul A. Insel, "Analgesic-Antipyretics and Antiinflammatory Agents; Drugs Employed in the Treatment of Rheumatoid Arthritis and Gout", Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th Ed., Chapter 26, pp. 638-641 (1990).
David L. Epstein, M.D., "Glaucoma", Chandler and Grant's 3rd Edition, pp. 3-5, 129-143, 181-183, 191, 194-195, 201-211, 293-294, 311, 320-321, 352-379, 396 and 403-407 (1986).
Jon R. Polansky, Md, "Side Effects of Topical Ophthalmic Therapy With Anti-Inflammatory Steroids and .beta.-Blockers", Current Opinion in Ophthalmology, vol. 3, 1992, pp. 259-272.
Jon R. Polansky, E. Bloom, G. M. Lui, A. Baur and D. J. Fauss, "Growth Factor Effects and Modulation of Glucocorticoid (GC) and Other Stress Responses in Human Trabecular Meshwork (HTM) Cells", Experimental Eye Research, vol. 55, Suppl. 1, Sep. 1992.
Jon R. Polansky, MD, "Basics Pharmacology of Corticosteroids", Current Topics in Ocular Inflammation, No. 1, 1993, pp. 9-21.
Jon R. Polansky, "HTM Cell Culture Model For Steroid Effects on Intraocular Pressure: Overview", Basic Aspects of Glaucoma Research III, Sep. 23-25, 1991, pp. 307-343.
Bloom Ernest
Fauss Donald J.
Polansky Jon R.
Griffin Ronald W.
The Regents of the University of California
LandOfFree
Preventing and treating elevated intraocular pressure associated does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preventing and treating elevated intraocular pressure associated, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preventing and treating elevated intraocular pressure associated will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1359809